Cerner Announces Quarterly Dividend
May 22 2020 - 9:00AM
Cerner Corporation (Nasdaq: CERN), a global health care technology
company, today announced that its Board of Directors declared a
cash dividend to stockholders of $0.18 per issued and outstanding
share. The cash dividend will be payable on July 17, 2020, to
shareholders of record as of the close of business on June 5, 2020.
Cerner intends to pay regular quarterly cash dividends, with
future declarations subject to approval by its Board of Directors
and their determination that the declaration of dividends remains
in the best interests of Cerner and its shareholders. The decision
of whether to pay future dividends and the amount of any such
dividends will be based on the company's financial position,
results of operations, cash flows, capital requirements, the
requirements of applicable law and any other factors the Board of
Directors may deem relevant.
About CernerCerner Corporation’s
health technologies connect people and information systems in
thousands of contracted provider facilities worldwide dedicated to
creating smarter and better care for individuals and communities.
Recognized globally for innovation, Cerner assists clinicians in
making care decisions and assists organizations in managing the
health of their populations. The company also offers an integrated
clinical and financial system to help manage day-to-day revenue
functions, as well as a wide range of services to support clinical,
financial and operational needs, focused on people. For more
information, visit Cerner.com, The Cerner Blog or connect
on Facebook, Instagram, LinkedIn, Twitter or The
Cerner Podcast. Nasdaq: CERN. Health care is too
important to stay the same.
All statements in this press release that do not
directly and exclusively relate to historical facts constitute
forward-looking statements. These forward-looking statements are
based on the current beliefs, expectations and assumptions of
Cerner's management with respect to future events and are subject
to a number of significant risks and uncertainties. It is important
to note that Cerner's performance, and actual results, financial
condition or business could differ materially from those expressed
in such forward- looking statements. The words "intends," "future,"
or the negative of these words, variations thereof or similar
expressions are intended to identify such forward-looking
statements. For example, our forward-looking statements include
statements regarding future dividends. Factors that could cause or
contribute to such differences include, but are not limited to the
possibility of significant costs and reputational harm related to
product and service-related liabilities; potential claims for
system errors and warranties; the possibility of interruption at
our data centers or client support facilities, or those of third
parties with whom we have contracted (such as public cloud
providers), that could expose us to significant costs and
reputational harm; the possibility of increased expenses, exposure
to legal claims and regulatory actions and reputational harm
associated with a cyberattack or other breach in our IT security or
the IT security of third parties on which we rely; material adverse
resolution of legal proceedings or other claims or reputational
harm stemming from negative publicity related to such claims or
legal proceedings; risks associated with our global operations,
including without limitation greater difficulty in collecting
accounts receivable; risks associated with fluctuations in foreign
currency exchange rates; changes in tax laws, regulations or
guidance that could adversely affect our tax position and/or
challenges to our tax positions in the U.S. and non-U.S. countries;
risks associated with the unexpected loss or recruitment and
retention of key personnel or the failure to successfully develop
and execute succession planning to assure transitions of key
associates and their knowledge, relationships and expertise; risks
related to our dependence on strategic relationships and third
party suppliers, including any impact to the business of such
suppliers resulting from the COVID-19 pandemic; risks inherent with
business acquisitions or strategic investments and the failure to
achieve projected synergies; risks associated with volatility and
disruption resulting from global economic or market conditions,
including any impact thereon resulting from events such as the
COVID-19 pandemic; significant competition and our ability to
anticipate or respond quickly to market changes, changing
technologies and evolving pricing and deployment methods and to
bring competitive new solutions, devices, features and services to
market in a timely fashion; managing growth in the new markets in
which we offer solutions, health care devices or services; long
sales cycles for our solutions and services; risks inherent in
contracting with government clients, including without limitation,
complying with strict compliance and disclosure obligations,
navigating complex procurement rules and processes, and defending
against bid protests; risks associated with our outstanding and
future indebtedness, such as compliance with restrictive covenants,
which may limit our flexibility to operate our business; the
potential for losses resulting from asset impairment charges;
changing political, economic, regulatory and judicial influences,
which could impact the purchasing practices and operations of our
clients and increase costs to deliver compliant solutions and
services; non-compliance with laws, government regulation or
certain industry initiatives or failure to deliver solutions or
services that enable our clients to comply with laws or regulations
applicable to their businesses; variations in our quarterly
operating results; potential variations in our sales forecasts
compared to actual sales; inability to achieve expected operating
efficiencies and sustain or improve operating expense reductions;
risks that Cerner’s revenue growth may be lower than anticipated
and/or that the mix of revenue shifts to low margin revenue; risk
that our capital allocation strategy will not be fully implemented
or enhance long-term shareholder value; and the extent to which the
COVID-19 pandemic and measures taken in response thereto could
adversely affect our financial condition, future bookings and
results of operations, including risks associated with the impact
of the COVID-19 pandemic on collecting accounts receivable.
Additional discussion of these and other risks, uncertainties and
factors affecting Cerner's business is contained in Cerner's
filings with the Securities and Exchange Commission. The reader
should not place undue reliance on forward-looking statements,
since the statements speak only as of the date that they are made.
Except as required by law, Cerner undertakes no obligation to
update or revise forward-looking statements to reflect changed
assumptions, the occurrence of unanticipated events, or changes in
our business, results of operations or financial condition over
time.
Investor Contact: Allan Kells,
(816) 201-2445, akells@cerner.com Media
Contact: Misti Preston, (816) 299-2037,
mediarelations@cerner.com Cerner's Internet Home
Page: www.cerner.com
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Sep 2023 to Sep 2024